Fairpointe Capital’s QuidelOrtho QDEL Stock Holding History

Fairpointe Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$721K	Buy	+5,637	New	+$1.04M	1.09%	31

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fairpointe Capital's QDEL Position: Q1 2021 in Review

Fairpointe Capital opened a new position in QuidelOrtho (QDEL) in Q1 2021: 5,637 shares worth $721K. The stake represents 1.09% of the portfolio and ranks #31 among its holdings.

349 funds tracked by Wall St. Rank hold QDEL as of Q1 2021.

Fairpointe Capital held 5,637 shares of QuidelOrtho worth $721K as of Q1 2021.
QuidelOrtho was a new Fairpointe Capital position in Q1 2021.
QuidelOrtho made up 1.09% of Fairpointe Capital's portfolio in Q1 2021, its #31 holding.
349 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2021.

Based on Fairpointe Capital's 13F filing for Q1 2021, filed 13 May 2021.